Integra, Novation combine in orthopaedic pact
This article was originally published in Clinica
Executive Summary
Regenerative medicine Integra LifeSciences (Plainsboro, New Jersey) has signed a three-year deal with US healthcare contracting service Novation for its Integra Mozaik osteoconductive scaffold. This deal will see Novation make the Mozaik technology available to members of the VHA, UHC and Provista healthcare purchasing networks – Integra claims that these three networks used Novation contracts to purchase more than $33.1bn of equipment in 2007. Integra’s collagen ceramic bone graft substitute technology is designed for use as a bone void filler and to allow for bone growth. Financial terms of the deal were not disclosed.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals